{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:55:19Z","timestamp":1761062119342,"version":"3.44.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.clineuro.2025.109048","type":"journal-article","created":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T17:54:45Z","timestamp":1751824485000},"page":"109048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Factors associated with complications in reversible cerebral vasoconstriction syndrome: A seven-year study at a comprehensive stroke center"],"prefix":"10.1016","volume":"257","author":[{"given":"Constance","family":"McGraw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Peralta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0971-826X","authenticated-orcid":false,"given":"Yasaman","family":"Pirahanchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6651-7286","authenticated-orcid":false,"given":"Christian","family":"Burrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Nieberlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Bar-Or","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell","family":"Bartt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.clineuro.2025.109048_bib1","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-023-11708-z","article-title":"Complications of reversible cerebral vasoconstriction syndrome in relation to age","volume":"270","author":"Lange","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.clineuro.2025.109048_bib2","article-title":"Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome (RCVS)","volume":"88","author":"A.B. S","year":"2017","journal-title":"Primum Non nocere! Stroke"},{"issue":"10","key":"10.1016\/j.clineuro.2025.109048_bib3","doi-asserted-by":"crossref","DOI":"10.1177\/17474930231181250","article-title":"Reversible cerebral vasoconstriction syndrome: a review of pathogenesis, clinical presentation, and treatment","volume":"18","author":"Singhal","year":"2023","journal-title":"Int. J. Stroke"},{"issue":"12","key":"10.1016\/j.clineuro.2025.109048_bib4","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1161\/STROKEAHA.121.034424","article-title":"Outcomes among patients with reversible cerebral vasoconstriction syndrome: A nationwide United States analysis","volume":"52","author":"Patel","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.clineuro.2025.109048_bib5","doi-asserted-by":"crossref","unstructured":"Singhal A.B., Topcuoglu M.A.. Glucocorticoid-Associated Worsening in Reversible Cerebral Vasoconstriction Syndrome.; 2016.","DOI":"10.1016\/B978-0-323-29544-4.00037-2"},{"issue":"8","key":"10.1016\/j.clineuro.2025.109048_bib6","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/archneurol.2011.68","article-title":"Reversible cerebral vasoconstriction syndromes: analysis of 139 cases","volume":"68","author":"Singhal","year":"2011","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2025.109048_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2013.4639","article-title":"Clinical worsening in reversible cerebral vasoconstriction syndrome","volume":"71","author":"Katz","year":"2014","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.clineuro.2025.109048_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/2396987316656981","article-title":"Gender and hormonal influences in reversible cerebral vasoconstriction syndrome","volume":"1","author":"Topcuoglu","year":"2016","journal-title":"Eur. Stroke J."},{"issue":"12","key":"10.1016\/j.clineuro.2025.109048_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awm256","article-title":"The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients","volume":"130","author":"Ducros","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2025.109048_bib10","article-title":"Unilateral reversible cerebral vasoconstriction syndrome (RCVS) after ipsilateral carotid endarterectomy (CEA) for severe symptomatic internal carotid artery (ICA) Stenosis: case report","volume":"41","author":"M. A","year":"2016","journal-title":"Cerebrovasc. Dis."},{"issue":"45","key":"10.1016\/j.clineuro.2025.109048_bib11","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017170","article-title":"Analysis of postpartum reversible cerebral vasoconstriction syndrome in China: a case report and literature review","volume":"98","author":"Liu","year":"2019","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.clineuro.2025.109048_bib12","doi-asserted-by":"crossref","DOI":"10.2169\/internalmedicine.5687-20","article-title":"Marijuana-related reversible cerebral vasoconstriction syndrome","volume":"60","author":"Mikami","year":"2021","journal-title":"Intern. Med."},{"issue":"4","key":"10.1016\/j.clineuro.2025.109048_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/0333102417715223","article-title":"Characteristics and demographics of reversible cerebral vasoconstriction syndrome: a large prospective series of Korean patients","volume":"38","author":"Choi","year":"2018","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1016\/j.clineuro.2025.109048_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/head.12794","article-title":"Reversible cerebral vasoconstriction syndrome without typical thunderclap headache","volume":"56","author":"Wolff","year":"2016","journal-title":"Headache"},{"key":"10.1016\/j.clineuro.2025.109048_bib15","unstructured":"Jensen J., Leonard J., Salottolo K., Mccarthy K., Wagner J., Bar-Or D. The Epidemiology of Reversible Cerebral Vasoconstriction Syndrome in Patients at a Colorado Comprehensive Stroke Center."},{"issue":"11","key":"10.1016\/j.clineuro.2025.109048_bib16","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.clineuro.2013.08.014","article-title":"Reversible cerebral vasoconstriction syndrome identification of prognostic factors","volume":"115","author":"Robert","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"2","key":"10.1016\/j.clineuro.2025.109048_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16564","article-title":"Retrospective analysis of 80 patients diagnosed with reversible cerebral vasoconstriction syndrome in the Helsinki Metropolitan Area","volume":"32","author":"Girfanova","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clineuro.2025.109048_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/15910199241285501","article-title":"Hemorrhagic versus non-hemorrhagic presentation of presumed reversible cerebral vasoconstriction syndrome (RCVS): presentations and outcomes","author":"Madapoosi","year":"2024","journal-title":"Interv. Neuroradiol."},{"issue":"4","key":"10.1016\/j.clineuro.2025.109048_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/STROKEAHA.123.046312","article-title":"Reversible cerebral vasoconstriction syndrome and female sex: a narrative review","volume":"55","author":"Nelson","year":"2024","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.clineuro.2025.109048_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/STROKEAHA.109.572313","article-title":"Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors","volume":"41","author":"Ducros","year":"2010","journal-title":"Stroke"},{"issue":"23","key":"10.1016\/j.clineuro.2025.109048_bib21","doi-asserted-by":"crossref","DOI":"10.2169\/internalmedicine.55.7185","article-title":"Triptan-induced reversible cerebral vasoconstriction syndrome: two case reports with a literature review","volume":"55","author":"Kato","year":"2016","journal-title":"Intern. Med."},{"issue":"1","key":"10.1016\/j.clineuro.2025.109048_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-022-00857-4","article-title":"Pathophysiology of reversible cerebral vasoconstriction syndrome","volume":"29","author":"Chen","year":"2022","journal-title":"J. Biomed. Sci."},{"issue":"3","key":"10.1016\/j.clineuro.2025.109048_bib23","doi-asserted-by":"crossref","DOI":"10.2169\/internalmedicine.9776-22","article-title":"Reversible cerebral vasoconstriction syndrome patients with a history of migraine: a retrospective case-control study","volume":"62","author":"Imai","year":"2023","journal-title":"Intern. Med."},{"issue":"5","key":"10.1016\/j.clineuro.2025.109048_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11050601","article-title":"Reversible cerebral vasoconstriction syndrome associated with levonorgestrel-releasing intrauterine system","volume":"11","author":"Choi","year":"2021","journal-title":"Brain Sci."},{"issue":"4","key":"10.1016\/j.clineuro.2025.109048_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/head.12797","article-title":"The typical thunderclap headache of reversible cerebral vasoconstriction syndrome and its various triggers","volume":"56","author":"Ducros","year":"2016","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.clineuro.2025.109048_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/head.13229","article-title":"Risk of stroke associated with use of estrogen containing contraceptives in women with migraine: a systematic review","volume":"58","author":"Sheikh","year":"2018","journal-title":"Headache"},{"key":"10.1016\/j.clineuro.2025.109048_bib27","doi-asserted-by":"crossref","DOI":"10.2147\/NDT.S285863","article-title":"Patterns of migraine in postmenopausal women: a systematic review","volume":"17","author":"Ornello","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.clineuro.2025.109048_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2020.07.005","article-title":"Menstrual and perimenopausal migraine: a narrative review","volume":"142","author":"MacGregor","year":"2020","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.clineuro.2025.109048_bib29","doi-asserted-by":"crossref","DOI":"10.1097\/GME.0000000000002311","article-title":"Migraines, vasomotor symptoms, and cardiovascular disease in the coronary artery risk development in young adults study","volume":"31","author":"Kim","year":"2024","journal-title":"Menopause"},{"key":"10.1016\/j.clineuro.2025.109048_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2019.105562","article-title":"Leuprolide acetate pseudomenopause therapy as a cause of reversible cerebral vasoconstriction syndrome","volume":"187","author":"Yamada","year":"2019","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"2","key":"10.1016\/j.clineuro.2025.109048_bib31","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00415-022-11425-z","article-title":"RCVS: by clinicians for clinicians\u2014a narrative review","volume":"270","author":"Erhart","year":"2023","journal-title":"J. Neurol."},{"issue":"8","key":"10.1016\/j.clineuro.2025.109048_bib32","doi-asserted-by":"crossref","DOI":"10.1177\/03331024241267316","article-title":"Drugs associated with reversible cerebral vasoconstriction syndrome: a pharmacovigilance study in vigiBase\u00ae","volume":"44","author":"Favreli\u00e8re","year":"2024","journal-title":"Cephalalgia"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846725003312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846725003312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T12:13:45Z","timestamp":1757074425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846725003312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":32,"alternative-id":["S0303846725003312"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.109048","relation":{},"ISSN":["0303-8467"],"issn-type":[{"type":"print","value":"0303-8467"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with complications in reversible cerebral vasoconstriction syndrome: A seven-year study at a comprehensive stroke center","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.109048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109048"}}